Literature DB >> 15463585

Estimation of population at risk of infection and number of cases of Leishmaniasis.

R W Ashford1, P Desjeux, P Deraadt.   

Abstract

In this paper, Dick Ashford, Philippe Desjeux and Peter deRaadt attempt to estimate the total number of people at risk of acquiring disease caused by infection with Leishmania spp. In many areas a very small risk is distributed among large numbers of people so, although the number of people at risk may be large, the number of infections may be very small. An estimate of the global annual incidence of new cases has also been made. This refers to reported clinical disease and probably grossly underestimates the number of infections. The methods by which the estimates have been made are specified so that they, as well as the estimates themselves, may be criticized and modified with some degree of objectivity.

Entities:  

Year:  1992        PMID: 15463585     DOI: 10.1016/0169-4758(92)90249-2

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  71 in total

1.  Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis.

Authors:  E C Torres-Santos; D L Moreira; M A Kaplan; M N Meirelles; B Rossi-Bergmann
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening.

Authors:  Suman Gupta; Shyam Sundar; Neena Goyal
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

3.  Evaluation of PCR for diagnosis of visceral leishmaniasis.

Authors:  O F Osman; L Oskam; E E Zijlstra; N C Kroon; G J Schoone; E T Khalil; A M El-Hassan; P A Kager
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Functional identification of a Leishmania gene related to the peroxin 2 gene reveals common ancestry of glycosomes and peroxisomes.

Authors:  J A Flaspohler; W L Rickoll; S M Beverley; M Parsons
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.

Authors:  Joseph L Amprey; Gerald F Späth; Steven A Porcelli
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani.

Authors:  R Bernier; S J Turco; M Olivier; M Tremblay
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  ELISA and western blotting for the detection of Hsp70 and Hsp83 antigens of Leishmania donovani.

Authors:  Jaspreet Kaur; Sukhbir Kaur
Journal:  J Parasit Dis       Date:  2012-07-03

8.  Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis.

Authors:  Tejinder Kaur; Ankita Thakur; Sukhbir Kaur
Journal:  J Parasit Dis       Date:  2012-09-06

9.  Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.

Authors:  R Mukhopadhyay; S Dey; N Xu; D Gage; J Lightbody; M Ouellette; B P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.

Authors:  M Chen; S B Christensen; J Blom; E Lemmich; L Nadelmann; K Fich; T G Theander; A Kharazmi
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.